NOF (4403) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
18 Nov, 2025Executive summary
H1 FY2025 net sales declined 1.2% year-on-year to ¥109,139 million, with operating profit down 11.5% to ¥20,648 million and profit attributable to owners of parent down 9.4% to ¥15,419 million.
The business environment was affected by global economic uncertainty, high raw material and fuel prices, and policy risks, though domestic consumption in Japan showed gradual recovery.
The company is targeting record-high net sales and profits for FY2025, with limited impact expected from U.S. tariff policy.
Continued focus on expanding business in life/healthcare, environment/energy, and electronics/IT, with ongoing innovation and cost reduction initiatives.
Financial highlights
H1 FY2025 net sales were ¥1,091 billion, down 1.2% year-over-year; operating profit fell 11.5% to ¥206 billion.
Ordinary profit decreased 8.3% to ¥216 billion; profit attributable to owners of parent dropped 9.4% to ¥154 billion.
Free cash flow increased to ¥206 billion in H1 FY2025 from ¥67 billion in H1 FY2024.
Comprehensive income rose to ¥19,226 million, up 3.9% year-on-year.
Basic earnings per share for the six months was ¥66.60, compared to ¥71.39 in the previous year.
Outlook and guidance
FY2025 forecast revised upward: net sales expected at ¥2,584 billion, operating profit at ¥460 billion, and profit at ¥382 billion.
Basic EPS forecasted at ¥166.2, up ¥8.6 from previous guidance.
Annual dividend for FY2025 revised up to ¥52 per share.
Full-year forecast for fiscal year ending March 31, 2026: net sales ¥258,400 million (up 8.4% year-on-year), operating profit ¥46,000 million (up 1.5%), ordinary profit ¥48,300 million (up 3.7%), profit attributable to owners of parent ¥38,200 million (up 4.7%), and basic EPS ¥166.18.
Latest events from NOF
- Net sales up, profits down; strong explosives growth; dividend and share buyback increased.4403
Q3 202613 Feb 2026 - Net sales rose slightly, but profits declined amid global uncertainty and higher costs.4403
Q1 20266 Aug 2025 - Sales and profits climbed in H1 FY2024, with guidance and shareholder returns both increased.4403
Q2 202513 Jun 2025 - Strong Q1 profit growth driven by Functional Chemicals; full-year outlook maintained.4403
Q1 202513 Jun 2025 - Record profits, higher dividends, and robust capital returns drive future growth.4403
Q4 20256 Jun 2025 - Sales and profits rose, driven by Functional Chemicals, with stable outlook and shareholder returns.4403
Q3 20255 Jun 2025